Article Eye Lids
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Corneal Ectasia
Corneal Ectasia Secretary for Quality of Care Anne L. Coleman, MD, PhD Academy Staff Nicholas P. Emptage, MAE Nancy Collins, RN, MPH Doris Mizuiri Jessica Ravetto Flora C. Lum, MD Medical Editor: Susan Garratt Design: Socorro Soberano Approved by: Board of Trustees September 21, 2013 Copyright © 2013 American Academy of Ophthalmology® All rights reserved AMERICAN ACADEMY OF OPHTHALMOLOGY and PREFERRED PRACTICE PATTERN are registered trademarks of the American Academy of Ophthalmology. All other trademarks are the property of their respective owners. This document should be cited as follows: American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern® Guidelines. Corneal Ectasia. San Francisco, CA: American Academy of Ophthalmology; 2013. Available at: www.aao.org/ppp. Preferred Practice Pattern® guidelines are developed by the Academy’s H. Dunbar Hoskins Jr., MD Center for Quality Eye Care without any external financial support. Authors and reviewers of the guidelines are volunteers and do not receive any financial compensation for their contributions to the documents. The guidelines are externally reviewed by experts and stakeholders before publication. Corneal Ectasia PPP CORNEA/EXTERNAL DISEASE PREFERRED PRACTICE PATTERN DEVELOPMENT PROCESS AND PARTICIPANTS The Cornea/External Disease Preferred Practice Pattern® Panel members wrote the Corneal Ectasia Preferred Practice Pattern® guidelines (“PPP”). The PPP Panel members discussed and reviewed successive drafts of the document, meeting in person twice and conducting other review by e-mail discussion, to develop a consensus over the final version of the document. Cornea/External Disease Preferred Practice Pattern Panel 2012–2013 Robert S. Feder, MD, Co-chair Stephen D. McLeod, MD, Co-chair Esen K. -
Whole Exome Sequencing Gene Package Vision Disorders, Version 6.1, 31-1-2020
Whole Exome Sequencing Gene package Vision disorders, version 6.1, 31-1-2020 Technical information DNA was enriched using Agilent SureSelect DNA + SureSelect OneSeq 300kb CNV Backbone + Human All Exon V7 capture and paired-end sequenced on the Illumina platform (outsourced). The aim is to obtain 10 Giga base pairs per exome with a mapped fraction of 0.99. The average coverage of the exome is ~50x. Duplicate and non-unique reads are excluded. Data are demultiplexed with bcl2fastq Conversion Software from Illumina. Reads are mapped to the genome using the BWA-MEM algorithm (reference: http://bio-bwa.sourceforge.net/). Variant detection is performed by the Genome Analysis Toolkit HaplotypeCaller (reference: http://www.broadinstitute.org/gatk/). The detected variants are filtered and annotated with Cartagenia software and classified with Alamut Visual. It is not excluded that pathogenic mutations are being missed using this technology. At this moment, there is not enough information about the sensitivity of this technique with respect to the detection of deletions and duplications of more than 5 nucleotides and of somatic mosaic mutations (all types of sequence changes). HGNC approved Phenotype description including OMIM phenotype ID(s) OMIM median depth % covered % covered % covered gene symbol gene ID >10x >20x >30x ABCA4 Cone-rod dystrophy 3, 604116 601691 94 100 100 97 Fundus flavimaculatus, 248200 {Macular degeneration, age-related, 2}, 153800 Retinal dystrophy, early-onset severe, 248200 Retinitis pigmentosa 19, 601718 Stargardt disease -
Congenital Ocular Anomalies in Newborns: a Practical Atlas
www.jpnim.com Open Access eISSN: 2281-0692 Journal of Pediatric and Neonatal Individualized Medicine 2020;9(2):e090207 doi: 10.7363/090207 Received: 2019 Jul 19; revised: 2019 Jul 23; accepted: 2019 Jul 24; published online: 2020 Sept 04 Mini Atlas Congenital ocular anomalies in newborns: a practical atlas Federico Mecarini1, Vassilios Fanos1,2, Giangiorgio Crisponi1 1Neonatal Intensive Care Unit, Azienda Ospedaliero-Universitaria Cagliari, University of Cagliari, Cagliari, Italy 2Department of Surgery, University of Cagliari, Cagliari, Italy Abstract All newborns should be examined for ocular structural abnormalities, an essential part of the newborn assessment. Early detection of congenital ocular disorders is important to begin appropriate medical or surgical therapy and to prevent visual problems and blindness, which could deeply affect a child’s life. The present review aims to describe the main congenital ocular anomalies in newborns and provide images in order to help the physician in current clinical practice. Keywords Congenital ocular anomalies, newborn, anophthalmia, microphthalmia, aniridia, iris coloboma, glaucoma, blepharoptosis, epibulbar dermoids, eyelid haemangioma, hypertelorism, hypotelorism, ankyloblepharon filiforme adnatum, dacryocystitis, dacryostenosis, blepharophimosis, chemosis, blue sclera, corneal opacity. Corresponding author Federico Mecarini, MD, Neonatal Intensive Care Unit, Azienda Ospedaliero-Universitaria Cagliari, University of Cagliari, Cagliari, Italy; tel.: (+39) 3298343193; e-mail: [email protected]. -
Eleventh Edition
SUPPLEMENT TO April 15, 2009 A JOBSON PUBLICATION www.revoptom.com Eleventh Edition Joseph W. Sowka, O.D., FAAO, Dipl. Andrew S. Gurwood, O.D., FAAO, Dipl. Alan G. Kabat, O.D., FAAO Supported by an unrestricted grant from Alcon, Inc. 001_ro0409_handbook 4/2/09 9:42 AM Page 4 TABLE OF CONTENTS Eyelids & Adnexa Conjunctiva & Sclera Cornea Uvea & Glaucoma Viitreous & Retiina Neuro-Ophthalmic Disease Oculosystemic Disease EYELIDS & ADNEXA VITREOUS & RETINA Blow-Out Fracture................................................ 6 Asteroid Hyalosis ................................................33 Acquired Ptosis ................................................... 7 Retinal Arterial Macroaneurysm............................34 Acquired Entropion ............................................. 9 Retinal Emboli.....................................................36 Verruca & Papilloma............................................11 Hypertensive Retinopathy.....................................37 Idiopathic Juxtafoveal Retinal Telangiectasia...........39 CONJUNCTIVA & SCLERA Ocular Ischemic Syndrome...................................40 Scleral Melt ........................................................13 Retinal Artery Occlusion ......................................42 Giant Papillary Conjunctivitis................................14 Conjunctival Lymphoma .......................................15 NEURO-OPHTHALMIC DISEASE Blue Sclera .........................................................17 Dorsal Midbrain Syndrome ..................................45 -
An Operation for Congenital Ptosis by George Young
Br J Ophthalmol: first published as 10.1136/bjo.8.6.272 on 1 June 1924. Downloaded from 272 THE BRITISH JOURNAL OF OPHTHALMIOI,OGY added plus lenses (eye being under atropin), J.2, fluently. This made her left eye equal, for distance, to her better eye, which is now getting worse owing to increased bulging, and will probably follow the course of the other one soon. R.V.: 6/36, c. -1.OD sph. + 3.50D cyl. 1550: 6/24 and J.5. Furthermore, it may be noted that the intraocular tension was now normal on the side of the iridectomy, while the right eye was hard, and I submitted it again to pilocarpin and bandage at night. I sent her home for a fortnight to feed up, take malt and cod liver oil and fats, and to take plenty of rest and recuperate. On July 8 the final result was: L.V.: 6/36, c.-5.OD sph. +3.50D cyl. 1600: 6/12 full, and -3.OD sph. and +3.50D cyl. J.2. Soon I shall tattoo the stellate leucoma with an artificial pupil. May 10, 1924. Since writing the above, some ten months ago, affairs have kept steady. There is no bulging of the left cornea or scar. I attempted tattooing at two sittings, and have considerably diminished the glare of the scar, but I refrain from risking the deep tattooing necessary for securing an imitation round black pupil, fearing to do harm. Glasses were prescribed and worn with comfort and great help, the vision being maintained as above. -
The Management of Congenital Malpositions of Eyelids, Eyes and Orbits
Eye (\988) 2, 207-219 The Management of Congenital Malpositions of Eyelids, Eyes and Orbits S. MORAX AND T. HURBLl Paris Summary Congenital malformations of the eye and its adnexa which are multiple and varied can affect the whole eyeball or any part of it, as well as the orbit, eyelids, lacrimal ducts, extra-ocular muscles and conjunctiva. A classification of these malformations is presented together with the general principles of treatment, age of operating and surgical tactics. The authors give some examples of the anatomo-clinical forms, eyelid malpositions such as entropion, ectropion, ptosis, levator eyelid retraction, medial canthus malposition, congenital eyelid colobomas, and congenital orbital abnormalities (Craniofacial stenosis, orbi tal plagiocephalies, hypertelorism, anophthalmos, microphthalmos and cryptophthalmos) . Congenital malformations of the eye and its as echography, CT-scan and NMR, enzymatic adnexa are multiple and varied. They can work-up or genetic studies (Table I). affect the whole eyeball or any part of it, as Surgical treatment when feasible will well as the orbit, eyelids, lacrimal ducts extra encounter numerous problems; age will play a ocular muscles and conjunctiva. role, choice of a surgical protocol directly From the anatomical point of view, the fol related to the existing complaints, and coop lowing can be considered. eration between several surgical teams Position abnormalities (malpositions) of (ophthalmologic, plastic, cranio-maxillo-fac one or more elements and formation abnor ial and neurosurgical), the ideal being to treat malities (malformations) of the same organs. Some of these abnormalities are limited to Table I The manag ement of cong enital rna/positions one organ and can be subjected to a relatively of eyelid s, eyes and orbits simple and well recognised surgical treat Ocular Findings: ment. -
Upper Eyelid Ptosis Revisited Padmaja Sudhakar, MBBS, DNB (Ophthalmology) Qui Vu, BS, M3 Omofolasade Kosoko-Lasaki, MD, MSPH, MBA Millicent Palmer, MD
® AmericAn JournAl of clinicAl medicine • Summer 2009 • Volume Six, number Three 5 Upper Eyelid Ptosis Revisited Padmaja Sudhakar, MBBS, DNB (Ophthalmology) Qui Vu, BS, M3 Omofolasade Kosoko-Lasaki, MD, MSPH, MBA Millicent Palmer, MD Abstract Epidemiology of Ptosis Blepharoptosis, commonly referred to as ptosis is an abnormal Although ptosis is commonly encountered in patients of all drooping of the upper eyelid. This condition has multiple eti- ages, there are insufficient statistics regarding the prevalence ologies and is seen in all age groups. Ptosis results from a con- and incidence of ptosis in the United States and globally.2 genital or acquired weakness of the levator palpebrae superioris There is no known ethnic or sexual predilection.2 However, and the Muller’s muscle responsible for raising the eyelid, dam- there have been few isolated studies on the epidemiology of age to the nerves which control those muscles, or laxity of the ptosis. A study conducted by Baiyeroju et al, in a school and a skin of the upper eyelids. Ptosis may be found isolated, or may private clinic in Nigeria, examined 25 cases of blepharoptosis signal the presence of a more serious underlying neurological and found during a five-year period that 52% of patients were disorder. Treatment depends on the underlying etiology. This less than 16 years of age, while only 8% were over 50 years review attempts to give an overview of ptosis for the primary of age. There was a 1:1 male to female ratio in the study with healthcare provider with particular emphasis on the classifica- the majority (68%) having only one eye affected. -
Clinical Manifestations of Congenital Aniridia
Clinical Manifestations of Congenital Aniridia Bhupesh Singh, MD; Ashik Mohamed, MBBS, M Tech; Sunita Chaurasia, MD; Muralidhar Ramappa, MD; Anil Kumar Mandal, MD; Subhadra Jalali, MD; Virender S. Sangwan, MD ABSTRACT Purpose: To study the various clinical manifestations as- were subluxation, coloboma, posterior lenticonus, and sociated with congenital aniridia in an Indian population. microspherophakia. Corneal involvement of varying degrees was seen in 157 of 262 (59.9%) eyes, glaucoma Methods: In this retrospective, consecutive, observa- was identified in 95 of 262 (36.3%) eyes, and foveal hy- tional case series, all patients with the diagnosis of con- poplasia could be assessed in 230 of 262 (87.7%) eyes. genital aniridia seen at the institute from January 2005 Median age when glaucoma and cataract were noted to December 2010 were reviewed. In all patients, the was 7 and 14 years, respectively. None of the patients demographic profile, visual acuity, and associated sys- had Wilm’s tumor. temic and ocular manifestations were studied. Conclusions: Congenital aniridia was commonly as- Results: The study included 262 eyes of 131 patients sociated with classically described ocular features. with congenital aniridia. Median patient age at the time However, systemic associations were characteristically of initial visit was 8 years (range: 1 day to 73 years). Most absent in this population. Notably, cataract and glau- cases were sporadic and none of the patients had par- coma were seen at an early age. This warrants a careful ents afflicted with aniridia. The most common anterior evaluation and periodic follow-up in these patients for segment abnormality identified was lenticular changes. -
Post-Thyroidectomy Iatrogenic Horner's Syndrome with Heterochromia
HOSTED BY Available online at www.sciencedirect.com ScienceDirect Journal of Current Ophthalmology 28 (2016) 46e47 http://www.journals.elsevier.com/journal-of-current-ophthalmology Case report Post-thyroidectomy iatrogenic Horner's syndrome with heterochromia Mahmut Oguz Ulusoy a,*, Sertaç Argun Kıvanç b, Mehmet Atakan c,Hu¨seyin Mayalı d a Department of Ophthalmology, Tarsus State Hospital, Mersin, Turkey b Department of Ophthalmology, Uludag University Faculty of Medicine, Bursa, Turkey c Department of Ophthalmology, Aksaray State Hospital, Aksaray, Turkey d Department of Ophthalmology, Celal Bayar University Faculty of Medicine, Manisa, Turkey Received 14 October 2015; revised 20 February 2016; accepted 20 February 2016 Available online 30 March 2016 Abstract Purpose: To present a case of iatrogenic Horner's syndrome seen together with the heterochromia in the post-thyroidectomy period. Methods: A 23-year-old female patient was admitted to our clinic with complaints of low vision in the eye and difference in eye color that developed over the past two years. In the left eye, myosis and minimal ptosis (~1 mm) was detected, and the color of the iris was lighter than the right eye. Results: The pre-diagnosis of left iatrogenic Horner's syndrome was finalized after 0.5% topical apraclonidine test. Conclusion: Heterochromia can be observed in iatrogenic Horner's syndrome. Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY- NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Keywords: Heterochromia iridis; Horner's syndrome; Thyroidectomy; Anisocoria Introduction over the past two to three years. -
Bilateral Ptosis and Lower Eyelid Ectropion Secondary to Cutaneous Leishmaniasis
CLINICOPATHOLOGIC REPORT Bilateral Ptosis and Lower Eyelid Ectropion Secondary to Cutaneous Leishmaniasis Imtiaz A. Chaudhry, MD, PhD; Camille Hylton, MS; Beatrice DesMarchais, MD 73-year-old white woman had a 14-month history of an extensive, disfiguring facial le- sion involving the cheeks, nose, and eyelids, resulting in exposure keratopathy. A bi- opsy of the facial lesion established the diagnosis of cutaneous leishmania, and the le- sion responded to treatment with itraconazole. A Arch Ophthalmol. 1998;116:1244-1245 Leishmaniasis, a parasitic infection caused pion and ptosis with weakened levator pal- by a hemoflagellate protozoan of the ge- pebral superior function, requiring use of nus Leishmania, is rarely seen in the United her frontalis muscles to assist in lid eleva- States. It is endemic, however, in the Medi- tion. Visual acuity was correctable to 20/25 terranean littoral, the Middle East, Af- OD and 20/30 OS. Slitlamp examination re- rica, and Central Asia. With the current vealed bilateral inferior superficial punc- regularity of worldwide travel, physi- tate keratopathy and palpebral conjuncti- cians around the world must have an in- val injection and hypertrophy with dex of suspicion for this diagnosis. We de- granulation and diffuse papillae. The re- scribe a patient from Italy who had facial sults of the remainder of the ocular exami- cutaneous leishmaniasis and associated bi- nation were normal. Systemic examina- lateral ptosis, ectropion, and exposure tion did not reveal any lymphadenopathy keratopathy. or hepatosplenomegaly. -
Strabismus Developing After Unilateral and Bilateral Cataract Surgery in Children
Eye (2016) 30, 1210–1214 © 2016 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 0950-222X/16 www.nature.com/eye CLINICAL STUDY Strabismus developing R David, J Davelman, H Mechoulam, E Cohen, I Karshai and I Anteby after unilateral and bilateral cataract surgery in children Abstract Purpose To evaluate the prevalence and common in children with poor final visual risk factors of strabismus in children acuity. undergoing surgery for unilateral or bilateral Eye (2016) 30, 1210–1214; doi:10.1038/eye.2016.162; cataract with or without intraocular lens published online 29 July 2016 implantation. Methods Medical records of pediatric Introduction patients were evaluated from 2000 to 2011. Children undergoing surgery for unilateral The rate of strabismus associated with cataract or bilateral cataract with at least 1 year of in children has been reported to range from follow-up were included. Children with 20.5 to 86%.1 Strabismus is more prevalent in ocular trauma, prematurity, or co-existing children who have been operated for cataract systemic disorders were excluded. The than in the general pediatric population.2–8 following data were evaluated: strabismus Moreover, it occurs more frequently in patients pre- and post-operation; age at surgery; with unilateral than bilateral cataract.1 The post-operative aphakia or pseudophakia; association between timing of surgery or the use and visual acuity. of intra ocular lens (IOL) with development of Results Ninety patients were included, 40% strabismus is still not fully understood. had unilateral and 60% had bilateral cataracts. The main purpose of this study is to evaluate Follow-up was on average 51 months (range: the prevalence and risk factors of strabismus 12–130 months). -
Genetic Background-Dependent Role of Egr1 for Eyelid Development
Genetic background-dependent role of Egr1 for PNAS PLUS eyelid development Jangsuk Oha,b, Yujuan Wangc,1, Shida Chenc,1, Peng Lia,b, Ning Dua,b, Zu-Xi Yud, Donna Butchere, Tesfay Gebregiorgisa,b, Erin Strachanf, Ordan J. Lehmannf, Brian P. Brooksg, Chi-Chao Chanc,2, and Warren J. Leonarda,b,2 aLaboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892; bImmunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892; cLaboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892; dPathology Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892; ePathology/Histotechnology Laboratory, Leidos Biomedical Research, Inc., Frederick, MD 21702; fDepartment of Medical Genetics, University of Alberta, Edmonton AB, Canada T6G 2H7; and gOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892 Contributed by Warren J. Leonard, June 30, 2017 (sent for review May 3, 2017; reviewed by David Fisher and Anjana Rao) EGR1 is an early growth response zinc finger transcription factor with C57BL/6 mice. Furthermore, we confirmed EGR1 expression in broad actions, including in differentiation, mitogenesis, tumor sup- the developing eyelid by immunohistochemistry. We also show that − − − − pression, and neuronal plasticity. Here we demonstrate that Egr1 / crossing the Tyrc-2J-null allele to Egr1 / C57BL/6 mice results in mice on the C57BL/6 background have normal eyelid development, ocular abnormalities; however, these abnormalities were less severe − − but back-crossing to BALB/c background for four or five generations than those that occur in the Egr1 / BALB/c mice, which naturally resulted in defective eyelid development by day E15.5, at which time contain the Tyrc mutation.